Global Atezolizumab Market Growth 2025-2031

December 2025 | 79 pages | ID: GFB0C85E5C9EN
LP Information

Abstracts

The global Atezolizumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Atezolizumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Atezolizumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Atezolizumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Atezolizumab players cover Genentech (Roche), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Atezolizumab Industry Forecast” looks at past sales and reviews total world Atezolizumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Atezolizumab sales for 2025 through 2031. With Atezolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atezolizumab industry.

This Insight Report provides a comprehensive analysis of the global Atezolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atezolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Atezolizumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atezolizumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atezolizumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Atezolizumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Use: Single Drug
• Use: ChemOthersapy Combination

Segmentation by Application:

• Bladder Cancer
• Lung Cancer
• Advanced Triple-negative Breast Cancer
• Head and Neck Cancer
• Urothelial Carcinoma
• Renal Cell Carcinoma
• Hepatocellular Carcinoma (HCC)
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Genentech (Roche)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Atezolizumab market?

What factors are driving Atezolizumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Atezolizumab market opportunities vary by end market size?

How does Atezolizumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atezolizumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Atezolizumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Atezolizumab by Country/Region, 2020, 2024 & 2031
2.2 Atezolizumab Segment by Type
  2.2.1 Use: Single Drug
  2.2.2 Use: ChemOthersapy Combination
2.3 Atezolizumab Sales by Type
  2.3.1 Global Atezolizumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Atezolizumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Atezolizumab Sale Price by Type (2020-2025)
2.4 Atezolizumab Segment by Application
  2.4.1 Bladder Cancer
  2.4.2 Lung Cancer
  2.4.3 Advanced Triple-negative Breast Cancer
  2.4.4 Head and Neck Cancer
  2.4.5 Urothelial Carcinoma
  2.4.6 Renal Cell Carcinoma
  2.4.7 Hepatocellular Carcinoma (HCC)
  2.4.8 Others
2.5 Atezolizumab Sales by Application
  2.5.1 Global Atezolizumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Atezolizumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Atezolizumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Atezolizumab Breakdown Data by Company
  3.1.1 Global Atezolizumab Annual Sales by Company (2020-2025)
  3.1.2 Global Atezolizumab Sales Market Share by Company (2020-2025)
3.2 Global Atezolizumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Atezolizumab Revenue by Company (2020-2025)
  3.2.2 Global Atezolizumab Revenue Market Share by Company (2020-2025)
3.3 Global Atezolizumab Sale Price by Company
3.4 Key Manufacturers Atezolizumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Atezolizumab Product Location Distribution
  3.4.2 Players Atezolizumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION

4.1 World Historic Atezolizumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Atezolizumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Atezolizumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Atezolizumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Atezolizumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Atezolizumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atezolizumab Sales Growth
4.4 APAC Atezolizumab Sales Growth
4.5 Europe Atezolizumab Sales Growth
4.6 Middle East & Africa Atezolizumab Sales Growth

5 AMERICAS

5.1 Americas Atezolizumab Sales by Country
  5.1.1 Americas Atezolizumab Sales by Country (2020-2025)
  5.1.2 Americas Atezolizumab Revenue by Country (2020-2025)
5.2 Americas Atezolizumab Sales by Type (2020-2025)
5.3 Americas Atezolizumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atezolizumab Sales by Region
  6.1.1 APAC Atezolizumab Sales by Region (2020-2025)
  6.1.2 APAC Atezolizumab Revenue by Region (2020-2025)
6.2 APAC Atezolizumab Sales by Type (2020-2025)
6.3 APAC Atezolizumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Atezolizumab by Country
  7.1.1 Europe Atezolizumab Sales by Country (2020-2025)
  7.1.2 Europe Atezolizumab Revenue by Country (2020-2025)
7.2 Europe Atezolizumab Sales by Type (2020-2025)
7.3 Europe Atezolizumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atezolizumab by Country
  8.1.1 Middle East & Africa Atezolizumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Atezolizumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Atezolizumab Sales by Type (2020-2025)
8.3 Middle East & Africa Atezolizumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atezolizumab
10.3 Manufacturing Process Analysis of Atezolizumab
10.4 Industry Chain Structure of Atezolizumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Atezolizumab Distributors
11.3 Atezolizumab Customer

12 WORLD FORECAST REVIEW FOR ATEZOLIZUMAB BY GEOGRAPHIC REGION

12.1 Global Atezolizumab Market Size Forecast by Region
  12.1.1 Global Atezolizumab Forecast by Region (2026-2031)
  12.1.2 Global Atezolizumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Atezolizumab Forecast by Type (2026-2031)
12.7 Global Atezolizumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Genentech (Roche)
  13.1.1 Genentech (Roche) Company Information
  13.1.2 Genentech (Roche) Atezolizumab Product Portfolios and Specifications
  13.1.3 Genentech (Roche) Atezolizumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Genentech (Roche) Main Business Overview
  13.1.5 Genentech (Roche) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Atezolizumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Atezolizumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Use: Single Drug
Table 4. Major Players of Use: ChemOthersapy Combination
Table 5. Global Atezolizumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Atezolizumab Sales Market Share by Type (2020-2025)
Table 7. Global Atezolizumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Atezolizumab Revenue Market Share by Type (2020-2025)
Table 9. Global Atezolizumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Atezolizumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Atezolizumab Sale Market Share by Application (2020-2025)
Table 12. Global Atezolizumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Atezolizumab Revenue Market Share by Application (2020-2025)
Table 14. Global Atezolizumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Atezolizumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Atezolizumab Sales Market Share by Company (2020-2025)
Table 17. Global Atezolizumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Atezolizumab Revenue Market Share by Company (2020-2025)
Table 19. Global Atezolizumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Atezolizumab Producing Area Distribution and Sales Area
Table 21. Players Atezolizumab Products Offered
Table 22. Atezolizumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Atezolizumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Atezolizumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Atezolizumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Atezolizumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Atezolizumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Atezolizumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Atezolizumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Atezolizumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Atezolizumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Atezolizumab Sales Market Share by Country (2020-2025)
Table 35. Americas Atezolizumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Atezolizumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Atezolizumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Atezolizumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Atezolizumab Sales Market Share by Region (2020-2025)
Table 40. APAC Atezolizumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Atezolizumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Atezolizumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Atezolizumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Atezolizumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Atezolizumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Atezolizumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Atezolizumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Atezolizumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Atezolizumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Atezolizumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Atezolizumab
Table 52. Key Market Challenges & Risks of Atezolizumab
Table 53. Key Industry Trends of Atezolizumab
Table 54. Atezolizumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Atezolizumab Distributors List
Table 57. Atezolizumab Customer List
Table 58. Global Atezolizumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Atezolizumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Atezolizumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Atezolizumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Atezolizumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Atezolizumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Atezolizumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Atezolizumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Atezolizumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Atezolizumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Atezolizumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Atezolizumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Atezolizumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Atezolizumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Genentech (Roche) Basic Information, Atezolizumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Genentech (Roche) Atezolizumab Product Portfolios and Specifications
Table 74. Genentech (Roche) Atezolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Genentech (Roche) Main Business
Table 76. Genentech (Roche) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Atezolizumab
Figure 2. Atezolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atezolizumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Atezolizumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Atezolizumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Atezolizumab Sales Market Share by Country/Region (2024)
Figure 10. Atezolizumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Use: Single Drug
Figure 12. Product Picture of Use: ChemOthersapy Combination
Figure 13. Global Atezolizumab Sales Market Share by Type in 2025
Figure 14. Global Atezolizumab Revenue Market Share by Type (2020-2025)
Figure 15. Atezolizumab Consumed in Bladder Cancer
Figure 16. Global Atezolizumab Market: Bladder Cancer (2020-2025) & (K Pcs)
Figure 17. Atezolizumab Consumed in Lung Cancer
Figure 18. Global Atezolizumab Market: Lung Cancer (2020-2025) & (K Pcs)
Figure 19. Atezolizumab Consumed in Advanced Triple-negative Breast Cancer
Figure 20. Global Atezolizumab Market: Advanced Triple-negative Breast Cancer (2020-2025) & (K Pcs)
Figure 21. Atezolizumab Consumed in Head and Neck Cancer
Figure 22. Global Atezolizumab Market: Head and Neck Cancer (2020-2025) & (K Pcs)
Figure 23. Atezolizumab Consumed in Urothelial Carcinoma
Figure 24. Global Atezolizumab Market: Urothelial Carcinoma (2020-2025) & (K Pcs)
Figure 25. Atezolizumab Consumed in Renal Cell Carcinoma
Figure 26. Global Atezolizumab Market: Renal Cell Carcinoma (2020-2025) & (K Pcs)
Figure 27. Atezolizumab Consumed in Hepatocellular Carcinoma (HCC)
Figure 28. Global Atezolizumab Market: Hepatocellular Carcinoma (HCC) (2020-2025) & (K Pcs)
Figure 29. Atezolizumab Consumed in Others
Figure 30. Global Atezolizumab Market: Others (2020-2025) & (K Pcs)
Figure 31. Global Atezolizumab Sale Market Share by Application (2024)
Figure 32. Global Atezolizumab Revenue Market Share by Application in 2025
Figure 33. Atezolizumab Sales by Company in 2025 (K Pcs)
Figure 34. Global Atezolizumab Sales Market Share by Company in 2025
Figure 35. Atezolizumab Revenue by Company in 2025 ($ millions)
Figure 36. Global Atezolizumab Revenue Market Share by Company in 2025
Figure 37. Global Atezolizumab Sales Market Share by Geographic Region (2020-2025)
Figure 38. Global Atezolizumab Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Atezolizumab Sales 2020-2025 (K Pcs)
Figure 40. Americas Atezolizumab Revenue 2020-2025 ($ millions)
Figure 41. APAC Atezolizumab Sales 2020-2025 (K Pcs)
Figure 42. APAC Atezolizumab Revenue 2020-2025 ($ millions)
Figure 43. Europe Atezolizumab Sales 2020-2025 (K Pcs)
Figure 44. Europe Atezolizumab Revenue 2020-2025 ($ millions)
Figure 45. Middle East & Africa Atezolizumab Sales 2020-2025 (K Pcs)
Figure 46. Middle East & Africa Atezolizumab Revenue 2020-2025 ($ millions)
Figure 47. Americas Atezolizumab Sales Market Share by Country in 2025
Figure 48. Americas Atezolizumab Revenue Market Share by Country (2020-2025)
Figure 49. Americas Atezolizumab Sales Market Share by Type (2020-2025)
Figure 50. Americas Atezolizumab Sales Market Share by Application (2020-2025)
Figure 51. United States Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Canada Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 53. Mexico Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Brazil Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 55. APAC Atezolizumab Sales Market Share by Region in 2025
Figure 56. APAC Atezolizumab Revenue Market Share by Region (2020-2025)
Figure 57. APAC Atezolizumab Sales Market Share by Type (2020-2025)
Figure 58. APAC Atezolizumab Sales Market Share by Application (2020-2025)
Figure 59. China Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 60. Japan Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 61. South Korea Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Southeast Asia Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 63. India Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 64. Australia Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 65. China Taiwan Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 66. Europe Atezolizumab Sales Market Share by Country in 2025
Figure 67. Europe Atezolizumab Revenue Market Share by Country (2020-2025)
Figure 68. Europe Atezolizumab Sales Market Share by Type (2020-2025)
Figure 69. Europe Atezolizumab Sales Market Share by Application (2020-2025)
Figure 70. Germany Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 71. France Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 72. UK Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 73. Italy Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 74. Russia Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 75. Middle East & Africa Atezolizumab Sales Market Share by Country (2020-2025)
Figure 76. Middle East & Africa Atezolizumab Sales Market Share by Type (2020-2025)
Figure 77. Middle East & Africa Atezolizumab Sales Market Share by Application (2020-2025)
Figure 78. Egypt Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 79. South Africa Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 80. Israel Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 81. Turkey Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 82. GCC Countries Atezolizumab Revenue Growth 2020-2025 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Atezolizumab in 2025
Figure 84. Manufacturing Process Analysis of Atezolizumab
Figure 85. Industry Chain Structure of Atezolizumab
Figure 86. Channels of Distribution
Figure 87. Global Atezolizumab Sales Market Forecast by Region (2026-2031)
Figure 88. Global Atezolizumab Revenue Market Share Forecast by Region (2026-2031)
Figure 89. Global Atezolizumab Sales Market Share Forecast by Type (2026-2031)
Figure 90. Global Atezolizumab Revenue Market Share Forecast by Type (2026-2031)
Figure 91. Global Atezolizumab Sales Market Share Forecast by Application (2026-2031)
Figure 92. Global Atezolizumab Revenue Market Share Forecast by Application (2026-2031)